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In Colombia’s bottom socio-economic strata, 46.6% of children under two are anaemic. A prevalence of
above 20% falls within the WHO guidelines for daily supplementation with multiple micronutrient
powder (MNP). To evaluate the effect of daily MNP supplementation on anaemia amongst Colombian
children aged 12–24 months we ran a cluster RCT (n¼1440). In previous work, we found the intervention
had no impact on haemoglobin or anaemia in this population. In this current paper, we investigate this
null result and ﬁnd it cannot be explained by an underpowered study design, inaccurate measurements,
low adoption of and compliance with the intervention, or crowding out through dietary substitution. We
conclude that our intervention was ineffective at reducing rates of childhood anaemia because MNP itself
was inefﬁcacious in our population, rather than poor implementation of or adherence to the planned
intervention. Further analysis of our data and secondary data suggests that the evolution with age of
childhood anaemia in Colombia, and its causes, appear different from those in settings where MNP has
been effective. Firstly, rates of anaemia peak at much earlier ages and then fall rapidly. Secondly, anaemia
that remains after the ﬁrst year of life is relatively, and increasingly as children get older, unrelated to
iron deﬁciency. We suggest that factors during gestation, birth, breastfeeding and early weaning may be
important in explaining very high rates of anaemia in early infancy. However, the adverse effects of these
factors appear to be largely mitigated by the introduction of solid foods that often include meat. This
renders population wide MNP supplementation, provided after a diet of solid foods has become estab-
lished, an ineffective instrument with which to target Colombia’s childhood anaemia problem.
& 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Multiple micronutrient powder (MNP) has been described as
an effective and scalable way to combat childhood and infant
anaemia. The WHO, for instance, recommends population wide
daily MNP supplementation in settings where anaemia has a
prevalence of 20% or greater amongst under-twos. Anaemia affects
nearly half (46.6%) of under-twos in Colombia’s lowest socio-
economic strata. This rises to nearly 70% of 6–12 month olds
(own estimates using ENSIN 2010 data (Instituto Colombiano de
Bienestar Familiar, 2015)). Colombia in general, and its youngest
and most disadvantaged children in particular meet the WHO’s
criteria for MNP adoption. In an earlier paper (Attanasio et al.,r Ltd. This is an open access article2014) we evaluated a daily MNP supplementation intervention
targeted at children aged 12–24 months from the poorest house-
holds in Colombian small towns. We found no effect on childhood
anaemia. In this paper, we investigate why MNP supplementation
had no impact.
Early childhood anaemia
Anaemia refers to a sub-optimally low concentration of hae-
moglobin (Hb) in the blood which reduces its capacity to transport
oxygen. Very severe anaemia in young children probably increases
mortality rates (Brabin, Premji, & Verhoeff, 2001) while less severe
cases contribute to delays in children’s cognitive and motor
development (Grantham-McGregor & Ani, 2001; Thompson, Biggs,
& Pasricha, 2013).
Deﬁciencies of iron and other micronutrients, arising from
inadequate intake or poor absorption, are the most prominentunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Ozaltin, Shankar, & Subramanian, 2011). Rapid growth at the start
of life means infants’ requirements for micronutrients are high,
especially relative to body size and energy intake, whilst their
stores are low (World Health Organization, 2005). Coupled with
often unvaried diets, this leaves many young children extremely
vulnerable to nutritional anaemia. Iron deﬁciency is widely
reported to account for approximately half the cases of childhood
anaemia worldwide (DeMaeyer and Adiels-Tegman, 1985),
although the generalisability of this result is not well established
(Stoltzfus, 2001). Aside from micronutrient deﬁciencies, other
signiﬁcant causes of childhood anaemia are parasitic infections
and malaria, although the latter is not relevant in our regions of
Colombia.
Multiple micronutrient powder
Multiple micronutrient powder (MNP) was designed and
described as a cost-effective and scalable way to target nutritional
anaemia (Zlotkin et al., 2005). Single dose sachets of powder,
typically containing iron, zinc, vitamin A and other vitamins and
minerals, are sprinkled over a child’s food immediately prior to
consumption. Because MNP contains multiple micronutrients it
can simultaneously address different nutritional causes of anaemia
and could, therefore, be more effective than iron supplementation
alone. It is argued to be superior to tablets or drops through
overcoming problems of poor adherence (Zlotkin et al., 2005).
The previous empirical evidence on MNP is encouraging. On
the basis of a Cochrane systematic review (De-Regil, Suchdev, Vist,
Walleser, & Peña-Rosas, 2011), the WHO (World Health Organi-
zation, 2011a) recommended daily MNP supplementation for all
young children in populations with a prevalence of childhood
anaemia (in children under 2 years) greater than 20%. The forest
plot in Fig. 1 updates the evidence from that systematic review. It
includes all published randomised trials found through an exten-
sive but non-systematic search of literature published up to andFig. 1. Meta analysis of the effect of MNP interventions on mean haemoglobin. Random
in months at the start of intervention. WMD¼Weighted Mean Difference. Hb(BL)¼base
follow-up. Bottom row excludes our study. Studies weighted using effective sample size a
do not report the intra-cluster correlation coefﬁcient (ICC) we use 0.07 (mid point betwee
calculate the effective sample size. Details of all studies provided in Table A1.including November 2015, which compare MNP with iron to no
intervention, or a placebo, or MNP without iron, in populations of
children under two years at the start of the intervention (Attanasio
et al., 2014; Adu-Afarwuah et al., 2007; Giovannini et al., 2006;
Jack et al., 2012; Kounnavong et al., 2011; Lemaire et al., 2011;
Lundeen et al., 2010; Macharia-Mutie et al., 2012; Menon et al.,
2007; Suchdev et al., 2012; Sooﬁ et al., 2013; Sharieff, Bhutta,
Schauer, Tomlinson, & Zlotkin, 2006; Veenemans et al., 2011;
Zlotkin et al., 2013). Table A1 summarises each study. In ten of the
thirteen studies (excluding ours) the mean haemoglobin of the
group receiving MNP, controlling for baseline haemoglobin where
available, was signiﬁcantly higher than that of the control group.
Overall, a random effects meta-analysis estimates a Weighted
Mean Difference (WMD) in haemoglobin concentration across
these studies of 5.36 g/L (95% CI: 3.82–6.91 g/L).
Although the evidence for MNP is generally positive, the stu-
dies are drawn from diverse populations in terms of geography,
age and health (Table A1). The precise interventions also differed.
Thus, we would expect substantial heterogeneity in effects
between studies. Indeed, the estimated I-squared of 79.7%
(excluding our trial) suggests that almost four ﬁfths of the total
variation between studies is due to heterogeneity, rather than
sampling variation. In the context of meta-analyses of health
interventions, this is high (Higgins, Thompson, Deeks, & Altman,
2003).
In general, the studies in Asia had substantially greater impacts
on haemoglobin than those in Africa, although even within geo-
graphic regions the degree of heterogeneity is large (Fig. 1). On
average, studies with high levels of haemoglobin at baseline
recorded lower effect sizes. However, substantial heterogeneity
remains within subgroups of studies with similar mean baseline
haemoglobin.
In the face of signiﬁcant heterogeneity, estimated WMD from
meta-analyses are not particularly informative. They are poor
predictors of the effect in any one context and estimate a mean
effect for a poorly deﬁned group of populations (those whereeffects meta-analysis performed using STATA’s metan command. Age(months)¼age
line haemoglobin (g/L). Hb(FU-control)¼haemoglobin (g/L) of the control group at
ccounting for design effects in cluster randomised controlled trials. For studies that
n the two studies that report an ICC: Attanasio et al. (2014) and Jack et al. (2012)) to
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these estimates, alone, are ill-suited to create guidelines that will
be applied to broad populations. In response to this problem,
Stoltzfus (2014) argues for moving beyond a ‘black box’ approach
to understanding nutrition interventions and using mechanistic
evidence to understand generalisability of results to other settings.
This is what we attempt in this paper.
Hypotheses
In this paper, we take the null result of our Colombian MNP
intervention and the heterogeneity in the estimated effects of
MNP reported by other studies as a starting point. After examining
the accuracy of our measurements and the power of the study
design, we further investigate the null result by considering three
sets of hypotheses. First, we assess the hypotheses that MNP was
effective for two subpopulations of children for whom we might
anticipate larger impacts – children with lower concentrations of
haemoglobin at baseline and younger children. Second, we explore
whether ineffectiveness of MNP was due to poor implementation
or indirect behavioural effects (i.e. whether MNP may still have
been efﬁcacious despite being ineffective). In particular, we
examine whether no effects of MNP were detected because of
either (i) low adoption of or compliance with the intervention or
(ii) because MNP crowded out children’s consumption of micro-
nutrient rich foods. Thirdly, we analyse whether our intervention
was ineffective because the causes of anaemia amongst our
population are fundamentally different from those in populations
where similar interventions have been effective. Speciﬁcally, we
investigate the extent to which childhood anaemia in our popu-
lation is due to iron deﬁciency hence determining the extent to
which the iron supplementation element of MNP is well-suited to
address it.The MNP intervention
The MNP we used was ‘Sprinkles’ developed by the Sprinkles
Global Health Initiative. Each 1 g sachet, to be sprinkled over a
child’s meal daily, contains 12.5 mg iron (ferrous fumerate), 5 mg
zinc, 300 mg vitamin A, 30 mg vitamin C and 160 mg folic acid. This
safely meets the average child’s daily requirement of iron, Vitamin
A, Vitamin C and Folic Acid and the majority of their zinc
requirement (World Health Organization, 2005). Our intervention
supplemented the children daily for 18 months.
Our intervention and evaluation used the structures of Familias
en Acción (FeA), Colombia’s conditional cash transfer programme
which targets the lowest socio-economic strata (SISBEN level one)
which corresponds to roughly the poorest 16% of the population.
The MNP intervention was delivered by home visitors who were
local women and in 63% of cases were Madre Líderes, locally
elected female representatives of FeA beneﬁciaries. Home visitors
were paid $15,000 Colombian Pesos (US$40) a month. Before the
intervention began, home visitors in MNP intervention areas
received a ﬁve hour training session, led by a mentor.
The home visitors delivered the appropriate number of sachets
to households every fortnight. To minimise the sharing of sachets
across children in the household they provided enough sachets for
daily consumption of all children younger than six years. During
their ﬁrst visits, home visitors explained to the mothers (or pri-
mary carers) how to store and administer the MNP and what to do
in the event of side effects. This information was also contained in
a booklet that was given to the mothers. Mothers were asked to
record daily whether the target child had consumed MNP and,
when necessary, why not. In addition to general oversight thementors managed stock and procurement logistics and compiled
the charts of daily MNP intake.Methods
Study design and participants
Our study evaluated the impacts of Psychosocial Stimulation
(PS, see Attanasio et al. (2014) for details) and MNP supple-
mentation on child development, alone and in combination. The
study design followed a 22 clustered, factorial design with four
arms: (1) control, (2) PS, (3) MNP, and (4) PSþMNP. While we do
not discuss PS or its impacts, described in Attanasio et al. (2014),
we account for it fully in the analysis. The interventions were
rolled out between February and May 2010 and lasted for 18
months.
The study enroled FeA beneﬁciaries, who are amongst the
poorest 16% of the population, sampled from three geographical
regions: (i) Cundinamarca, Boyacá and Santander; (ii) Antioquia,
Risaralda and Caldas; and (iii) Huila and Tolima. In each region we
selected 32 small towns satisfying the following criteria: (i) FeA had
been in operation since it began in 2002; and (ii) the population was
between 2000 and 42,000. In each townwe randomly selected three
Madre Líders, after which we identiﬁed (through a door-to-door
census) all children in the target age range (12–24 months at
enrolment) living in families represented by these Madre Líders.
Amongst these children we randomly selected ﬁve for enrolment.
The target sample size was, therefore, 1440 (3x32x35) children.
Randomisation and masking
Our study randomly allocated eight towns from each of the
three regions to each of the four arms.
For practical reasons we did not use a placebo in areas that did
not receive MNP. It was not possible to blind participants to the PS
intervention. We made every effort to ensure testers were blind to
treatment allocation.
Outcomes
In analysing the impact of MNP on anaemia our preferred
outcome measure is continuous raw haemoglobin (over a binary
indicator of anaemia) because of uncertainty over optimal cut-offs
and how these should vary with age for young children (Beutler &
Waalen, 2006; Brault-Dubuc, Nadeau, & Dickie, 1983). However,
we also report anaemia for comparability with existing literature.
We measured haemoglobin using the HemoCue method, which
has been found a suitably accurate method in resource poor set-
tings (Nkrumah et al., 2011). We deﬁne anaemia using the WHO
cut-off of Hbo110 g/L with WHO altitude adjustments (World
Health Organization, 2011b).
We collected socio-economic characteristics and children’s intake
of 15 different foodstuffs (selected, through piloting, to include all
items common in a Colombian diet) during the past seven days
through maternal/carer report in a household questionnaire.
Statistical analysis
We perform all analysis using STATA (version 12) and adjust all
inference (standard errors, conﬁdence intervals and p-values) for
clustering at the town level, our unit of randomisation.
Validating measurements
We validate our measures of haemoglobin by assessing whe-
ther they correlate, assessed by Pearson’s correlation coefﬁcient,
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entheses): baseline haemoglobin (positive), altitude (positive), age
(positive), length-for-age z-scores (positive).
Power analysis
We analytically calculate the power of our design and regres-
sion estimator to detect a positive effect of MNP on haemoglobin
concentrations of children in the MNP only group relative to the
control, at a 5% signiﬁcance level, if the true ATE in our population
were equal to the weighted mean difference from the RE meta-
analysis (5.36 g/L). See Table A2 for analytic formula. In two sen-
sitivity analyses we use (1) the lower bound of conﬁdence interval
of estimated ATE from meta-analysis and (2) the standard error
from our unadjusted estimate.
Effects of MNP on anaemia and haemoglobin
Where haemoglobin is the dependent variable we use linear
regression and report adjusted and unadjusted mean differences.
Where anaemia is the binary dependent variable we use logistic
regression and report adjusted and unadjusted odds ratios. In
adjusted measures we control for sex, tester, region, second order
polynomials in age and altitude and the baseline value of the
dependent variable. We estimate the effect of MNP on haemoglobin
for two subsamples, younger children and those with lower hae-
moglobin measures at baseline using identical methodology.
Partial non-compliance analysis (instrumental variables)
We use an instrumental variables approach (Greenland, 2000)
to remove confounding factors when we account for partial non-
compliance and allow the impact to vary by treatment intensity. In
this method we require an instrumental variable that is correlated
with MNP consumption but independent of all other factors that
affect haemoglobin concentration. In our context, treatment status
is the obvious instrumental variable, as it is randomly assigned and
therefore uncorrelated with any unobservable determinant of
anaemia. It is also highly likely to be correlated with MNP con-
sumption and we test this using an F-test.
Analysing the coexistence of anaemia and iron deﬁciency
To analyse the dynamics of childhood anaemia in Colombia and
its relationship with iron deﬁciency, we use data on haemoglobin
and iron deﬁciency from the second Colombian national survey of
nutritional status, ENSIN 2010 (Instituto Colombiano de Bienestar
Familiar, 2015). From the ENSIN sample we take children aged 12–
42 months (the survey only collected ferritin measurements for
children over one year) from the poorest category of Colombia’sTable 1
Baseline characteristics.
Control MNPþPS
Age (months) 18.3 (4.0) 17.9 (
Male (%) 49.2 50.9
Stuntedb (%) 15.8 13.3
Haemoglobin (g/L) 114.5 (12.9) 113.6 (
Anaemiac (%) 47.4 45.4
Mother’s age (years) 26.1 (7.0) 26.7 (
Mother’s education (years) 7.4 (3.7) 7.4 (
Haemoglobin of mother (g/L) 134.0 (14.5) 133.1 (
Anaemia mother (%) 20.1 22.0
Number of people in household 5.2 (2.3) 5.2 (
N 321 324
Standard deviations in parentheses. Signiﬁcance stars refer to difference in means tests b
the town level): ***po0.01, **po0.05, *po0.1.
a p-Values for testing null hypothesis that mean characteristics are equal across all
b Stunting is deﬁned as a Z-score height-for-age o2SD.
c Anaemia is deﬁned in Section “Outcomes”.six-level categorisation system for determining eligibility for social
welfare programmes (SISBEN level one).
We estimate the share of anaemia that could likely be addressed
through supplementing children’s diets with iron by looking at the
coexistence of anaemia with iron deﬁciency. We ﬁrst use multiple
imputation (Sterne et al., 2009) to impute missing ferritin mea-
surements. Here we assume that ferritin measurements are missing
at random once we control for haemoglobin, height, weight, age,
sex, altitude and geographical area. Controlling for these (obser-
vable) variables in the imputation routine is important, since miss-
ing data (due to refusal for a venous blood sample to be taken) are
unlikely to occur at random. Next, we calculate the proportion of
anaemic children (Hbo110 g/L, adjusted for altitude) with iron
deﬁciency (ferritino12 mg/L) on the subsample of children who
show no evidence of infection (CRPo1.2 mg/L). We estimate this
separately for two sub-samples of the ENSIN survey – those aged
12–24 months (age at baseline in our study) and those aged 30–42
months (age at follow-up in our study).
We also use data on prevalence of anaemia by country from the
Demographic and Health Surveys (DHS) Program and PEDNSS
(Centers for Disease Control and Prevention, 2015). This enables us
to compare the pattern of anaemia we see in Colombia with other
countries. When more than one DHS survey is available for a
country we use the most recent.Results
Of the 1440 children we selected for our study, we excluded
from the analysis 11 who were out of the age range. Haemoglobin
measurements were taken for all but 33 children at baseline (1396
children). At follow-up, we retained 93.2% of the baseline sample
(1332 children) and obtained haemoglobin measurements for
1297. Our sample of analysis consists of the 1296 children for
whom we have haemoglobin measurements both at baseline and
follow-up.
There is evidence of differential attrition and missing hae-
moglobin measurements between treatment groups. A sig-
niﬁcantly higher proportion of the PS group (12.3%) and MNP
group (10.2%) than of the control group (5.6%) were either com-
pletely lost from the study at follow-up or were missing hae-
moglobin measurements (po0.05). Nonetheless, attrition and
missing haemoglobin are uncorrelated with baseline haemoglobin
and other key characteristics. Table 1 shows that our analysis
sample were well balanced in terms of key baseline characteristicsPS MNP p-Valuea
3.7) 18.0 (3.8) 17.9 (3.6) 0.785
46.1 52.8 0.375
13.3 10.8 0.401
13.1) 112.8 (13.0) 113.7 (12.7) 0.892
48.4 45.6 0.950
7.7) 26.7 (6.9) 26.0 (6.2) 0.462
3.5) 6.9 (3.6) 7.3 (3.6) 0.498
14.0) 131.7 (15.4) 131.6 (14.7) 0.743
22.5 22.7 0.953
2.1) 5.4 (2.3) 5.2 (2.1) 0.729
308 316
etween each intervention group and the control group, accounting for clustering (at
four groups, accounting for clustering at town level.
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ential attrition to bias our estimates.
Validity of study design
We calculate the power of our test to detect an average treat-
ment effect (ATE) on haemoglobin equal to an increase in hae-
moglobin of 5.36 g/L, corresponding to the weighted mean dif-
ference (WMD) from the meta-analysis of previous trials (Fig. 1).
Using an external benchmark, rather than our own estimated
treatment effect, for the ATE under the alternative hypothesis,
means our analysis does not fall foul of criticisms relevant to many
post-hoc power calculations (Hoenig and Eisey, 2001).
Using our estimated standard errors, we ﬁnd that the probability
that we would have rejected the null of a zero ATE (5% signiﬁcance
level, two-tailed hypothesis test), if the true ATE was equal to 5.36 g/
L, is greater than 0.99. In sensitivity analysis we obtain a power of
0.98 and 0.86, respectively, if we use the lower bound of the con-
ﬁdence interval of the estimated WMD (Fig. 1) or if we use the
estimated standard error from the unadjusted haemoglobin mea-
surements (all calculations presented in Table A2). Therefore, we can
be almost certain that had the true ATE in our population been
similar to the mean effect estimated in other studies, we would have
detected a positive impact on haemoglobin.
Validity of haemoglobin measurements
We measured haemoglobin using the HemoCue method which,
although not as precise as more expensive alternatives, has been
found to be suitably accurate in resource poor settings (Nkrumah
et al., 2011). The ﬁeldwork agency checked the machines before
and after ﬁeldwork and found that they were functioning satis-
factorily. We tested whether individual testers misused the
machines by comparing residual haemoglobin measurements
between testers, after controlling for important determinants ofTable 2
Intervention Impacts on anaemia and haemoglobin at follow-up, overall and by sub-gro
Control MNPþPS
Full sample
Anaemiab
%(Fraction) 26.480 (85/321) 18.827 (61/324)
Unadjusted OR (95%CI)c 0.644 (0.356, 1.166)
Adjusted OR (95%CI) 0.678 (0.423, 1.088)
Haemoglobin (g/L)
Mean(SD) 120.944 (12.065) 122.284 (11.275)
Unadjusted diff (95%CI) 1.340 (2.288, 4.968)
Adjusted diff (95%CI) 1.500 (0.309, 3.308)
N 321 324
Anaemic at baselinec
Haemoglobin (g/L)
Mean(SD) 118.171 (11.411) 119.279 (11.241)
Unadjusted diff (95%CI) 1.108 (3.027, 5.243)
Adjusted diff (95%CI) 0.933 (1.633, 3.498)
N 152 147
Younger than 18 months at baseline
Haemoglobin (g/L)
Mean(SD) 120.905 (11.173) 120.855 (11.816)
Unadjusted diff (95%CI) 0.050 (4.626, 4.527)
Adjusted diff (95%CI) 0.931 (1.697, 3.559)
N 137 154
All ‘adjusted’ quantities adjusted for sex, tester, region, second order polynomials in age
linear regression for haemoglobin. Conﬁdence intervals and p-values adjusted for cluste
a p-Value for null that (i) for anaemia: the ORs are one for all intervention groups vs.
is zero for all intervention groups vs. the alternative that they are not all zero.
b Anaemia is deﬁned in Section “Outcomes”.
c OR¼Odds Ratio, CI¼Conﬁdence Interval.haemoglobin. We found no evidence of this. In Table A3 we show
our haemoglobin measurements are correlated with age, altitude
and haemoglobin at baseline in the expected directions. We also
found that our measurements are consistent with the ENSIN 2010
data in terms of age and altitude gradients. Overall, there is no
evidence that inaccurate haemoglobin readings left us unable to
detect a true effect.
Effect of MNP on anaemia and haemoglobin
The baseline prevalence of anaemia (Hbo110 g/L, adjusted for
altitude) was 46.7% in the entire sample and balanced between
groups (Table 1). The ﬁrst panel in Table 2 reproduces the ﬁnding
of Attanasio et al. (2014) that, at follow-up, the prevalence of
anaemia more than halved to 21.0%. However, we see no sig-
niﬁcant difference between intervention groups. Likewise, mean
haemoglobin increased by 7.61 g/L from baseline but there is no
difference between groups. The null result remains in our adjusted
estimates.
We might expect to ﬁnd larger impacts for two subgroups of
children: (i) children who were anaemic at baseline and (ii)
younger children (since WHO recommends supplementation from
6 months and younger children have higher rates of anaemia).
However, the second and third panels in Table 2 show no evidence
of positive impacts for either subgroup. Further, in Fig. 2 we look
for the existence of threshold effects, where MNP might have been
effective for children with baseline haemoglobin below a certain
threshold. We plot our estimated effects of MNP and MNPþPS on
haemoglobin at follow-up for those children whose baseline
haemoglobin fell below successively lower thresholds (adjusted
for altitude). We see no evidence that there is any threshold below
which MNP has a signiﬁcant positive effect. If anything, the point
estimates become increasingly smaller and then negative for
children with the lowest haemoglobin at baseline. This subgroup
analysis suggests that, in addition to seeing no average beneﬁt ofups.
PS MNP p-Valuea
19.481 (60/308) 19.937 (63/316)
0.672 (0.382, 1.182) 0.691 (0.396, 1.206) 0.419
0.766 (0.483, 1.215) 0.677 (0.426, 1.074) 0.304
121.305 (11.864) 120.446 (11.874)
0.361 (3.484, 4.207) 0.498 (3.994, 2.997) 0.693
1.222 (0.475, 2.918) 0.272 (1.607, 2.152) 0.251
308 316
117.852 (11.577) 117.950 (11.666)
0.319 (4.081, 3.444) 0.221 (3.752, 3.310) 0.890
0.651 (1.673, 2.975) 0.343 (2.583, 1.897) 0.634
149 144
120.377 (12.139) 120.206 (12.127)
0.528 (5.064, 4.007) 0.700 (4.779, 3.380) 0.983
0.676 (1.689, 3.041) 0.063 (2.501, 2.626) 0.863
138 145
and altitude and baseline value of variable using logistic regression for anaemia and
ring at the town level.
the alternative that they are not all one or (ii) for haemoglobin: the mean difference
Fig. 2. Coefﬁcient plot of estimated effects of MNP on haemoglobin for subgroups
of children with baseline haemoglobin below successively lower thresholds. For
each baseline haemoglobin cut-off on the x-axis the plot shows the estimated effect
of MNP on follow-up haemoglobin for the subgroup of children whose baseline
haemoglobin was below that cut-off. Points represent point estimates and bars
represent the 95% conﬁdence interval around each estimate. All estimated effects
adjusted for sex, tester, region, second order polynomials in age and altitude and
baseline haemoglobin using linear regression. Conﬁdence intervals adjusted for
clustering at the town level.
Table 3
Reported MNP consumption for targeted children.
MNP MNPþPS Total
n % n % n %
Less than 6 months worth (1–180
sachets)
38 11.66 51 15.27 89 13.48
6–12 Months’ worth (181–360 sachets) 57 17.48 66 19.76 123 18.64
12–18 Months’ worth (361–546
sachets)
206 63.19 162 48.50 368 55.76
More than expected consumption
(4546 sachets)
25 7.67 55 16.47 80 12.12
Total adoption 326 91.32 334 92.78 660 92.05
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the two groups whom we might have expected it to be most
effective for.
One possibility that we cannot exclude is that the decline in
anaemia we observe between 12–24 months and 30–42 months
occurred faster in the MNP treatment groups. We only observe the
children 18 months after baseline, when the anaemia rate has
already converged to a low level in the overall population. How-
ever, if the MNP had had sizeable impacts on the timing of the
transition to a low anaemia rate, we might have expected to
observe impacts on other outcomes such as height, weight, cog-
nitive, language development 18 months after baseline, which we
did not (Attanasio et al., 2014).
High adoption and compliance
The supplement intake sheets completed by mothers/carers
suggest adoption of and compliance with the intervention was
high. Table 3 shows that 92% of targeted children adopted the
intervention (they consumed some supplements). This 92% con-
sumed a mean (median) of 72.5% (81.3%) of expected consump-
tion. Overall, 68% of targeted children consumed more than 12-
months-worth of supplements. Given our intervention providedMNP for longer than similar interventions (18 months compared
to the 2–12 months in the studies summarised in Table A1), it is
unlikely our null result is due to children consuming insufﬁcient
supplements to detect an effect had MNP been efﬁcacious in this
population.
We adopt an instrumental variables approach (described in
Section “Partial non-compliance analysis (instrumental variables)”)
to allow for partial non-compliance and for the effect on hae-
moglobin concentration to vary with MNP intake. From Table A4 we
see that treatment status is a strong instrument for supplement
intake (i.e. treatment status is highly correlated with intake) (F-
statistic¼334.37, p¼0.000). However, the estimated effect of MNP
on haemoglobin remains insigniﬁcant and close to zero (p¼0.733).
This suggests the null result in the intention-to-treat analysis is not
due to incomplete adoption and low compliance.
Since intake records are based on maternal report, a concern
might be that mothers over-reported consumption if they feared
non-compliance could affect their permanence in the intervention
or FeA more generally. However, one indication that this did not
occur is that mothers in the MNP-only group reported signiﬁcantly
higher consumption (mean¼403 sachets) than mothers in the
MNPþPS group (mean¼388 sachets) (po0.05). Since anecdotal
and qualitative evidence suggest that mothers greatly valued the
PS intervention, this suggests that they did not over-report for fear
of losing access to other beneﬁts. In addition, self-reported data
was corroborated by home visitors collecting used sachets. Men-
tors compared the two sources while processing the intake sheets
and found they coincided the vast majority of the time.
No dietary substitution
Our study design did not use a placebo. Therefore it is possible
that parents altered their children’s diet in response to MNP. For
example, parents in the MNP groups may have reduced the
quantity of iron rich food since MNP contained iron, a phenom-
enon reported by Murphy and Allen (2003), thereby mitigating the
effect of MNP. However, analysis of the extensive child food con-
sumption data shows no evidence of substitution away from iron
rich foods in the MNP groups vis-à-vis the control group (Table 4).
Coexistence of anaemia and iron deﬁciency
In our analysis of the ENSIN sample (described in Section
“Analysing the coexistence of anaemia and iron deﬁciency”), we
ﬁnd that of the 38.9% of 12–24 month olds (the age of our study
children at baseline) who are anaemic, 34.0% have iron deﬁciency,
typically considered to be the largest cause of anaemia. This sug-
gests that iron supplementation through MNP has the potential to
reverse anaemia through its iron supplementation element in a
relatively low proportion of the ENSIN sample of 12–24 month
olds – just the 13.2% who have both iron deﬁciency and anaemia.
When we repeat this analysis for the older ENSIN children (30–42
months) we ﬁnd that, in addition to the overall prevalence of
anaemia falling to 19.0%, the proportion of this anaemia that co-
exists with iron deﬁciency falls substantially to 15.1%. This sug-
gests that, by 30–42 months, the proportion of children in the
ENSIN sample whose anaemia status could plausibly be improved
by the iron supplementation element of MNP is just 2.9%.Discussion
The results presented in Sections “Validity of study design” to
“No dietary substitution” suggest that for Colombian children aged
12–24 months from poor backgrounds and living in small towns,
MNP supplementation is ineffective when delivered in real world
Table 4
Follow-up consumption of foodstuffs related to iron intake and absorption – number of days out of the last seven the child consumed the listed food.
Control MNPþPS PS MNP
Haem (highly absorbable) iron rich foods
Beef, liver etc. 3.643 (2.255) 3.796 (2.216) 3.638 (2.300) 3.838 (2.306)
Poultry 1.715 (1.470) 1.859 (1.424) 1.791 (1.565) 2.091* (1.613)
Swine, rabbit, lamb 0.279 (0.813) 0.411 (1.078) 0.494 (1.254) 0.298 (0.770)
Fish 0.520 (1.052) 0.524 (0.910) 0.553 (1.025) 0.579 (1.046)
Non-haem iron rich foods
Pulses (fresh) 1.492 (1.958) 1.473 (1.759) 1.741 (2.028) 1.042* (1.491)
Pulses (dried) 2.508 (1.858) 2.611 (1.812) 2.616 (1.900) 2.634 (1.853)
Bienestarina 2.912 (2.688) 2.900 (2.669) 2.837 (2.595) 3.123 (2.754)
Foods that may impair iron non-haem absorption
Rice 4.837 (2.399) 5.310 (2.275) 4.737 (2.327) 4.877 (2.313)
Bakery products and maize 4.730 (2.349) 4.821 (2.354) 4.800 (2.287) 4.696 (2.378)
Eggs 4.618 (2.349) 4.931 (2.271) 4.650 (2.181) 4.482 (2.216)
Milk or dairy products 6.342 (1.629) 6.179 (1.751) 6.125 (1.831) 6.314 (1.598)
Foods that may aid non-haem iron absorption
Potatoes, plantains etc. 5.254 (2.091) 5.448 (2.027) 5.353 (2.155) 5.184 (2.123)
Pumpkin, carrot, peppers, spinach 3.154 (2.321) 3.292 (2.495) 3.525 (2.487) 3.485 (2.387)
Fruits or juices 4.966 (2.403) 5.373 (2.239) 5.206 (2.333) 5.133 (2.223)
N 319 319 320 309
Standard deviations in parentheses. Signiﬁcance stars refer to difference in means tests between each intervention group and the control group, using cluster robust standard
errors: ***po0.01, **po0.05.
npo0.1. Refers to difference in means tests between each intervention group and the control group, using cluster robust standard errors.
Fig. 3. Prevalence of childhood anaemia by age across different regions. Colombian
data from ENSIN 2010 for sub-sample SISBEN level one households. USA data from
PEDNSS. Continent level data from all DHS surveys which collected childhood
anaemia rates. Most recent data used when more than one survey available. Country
data weighted by World Bank population estimates of children under four to esti-
mate the combined prevalence, grouped at the continent level. Countries included in
continent level averages are listed in the online appendix (Table A5).
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efﬁcacy. This ﬁnding holds even for children we might have
expected to beneﬁt the most – younger children and those who
were anaemic at baseline. Key to understanding this, when similar
interventions have been successful, is the progression of anaemia,
and its causes, with age in our population.
Nearly 70% of the poorest Colombian children aged 6–12
months are anaemic (Fig. 3), just 10 percentage points below rates
in South and Southeast Asia and Sub-Saharan Africa. However,
while anaemia appears very persistent in the Asian and African
countries, in Colombia, the rate falls very quickly, almost halving in
seven months and falling to 20%, a rate comparable to the USA, by
30 months. This trend appears similar to, but more pronounced
than, other countries in South America; and is very similar in the
evaluation sample we have analysed.
This pattern suggests that we targeted children who were
already too old to receive maximum beneﬁt from MNP. From Fig. 1
we notice that the studies that found MNP to be most effective at
increasing haemoglobin were those with very low average initial
haemoglobin (severe anaemia) and where the control group still
had very low levels at follow-up (persistent anaemia). In contrast,
at the time of our baseline survey mean haemoglobin in our study
population was the highest amongst all the studies listed in Fig. 1
and mean haemoglobin in the control group increased rapidly over
the duration of the intervention, from 114.5 g/L to 120.9 g/L. The
increase was even more dramatic for those controls that were
anaemic at baseline (104.2–118.2 g/L). This supports the idea that
our study began after and continued during a period of rapid
improvement in anaemia and so did not act in time to address the
nearly 70% of 6–12 month olds in Colombia (Fig. 3) who are
anaemic.
In Section “Coexistence of anaemia and iron deﬁciency” we
show that just over a third of anaemia co-exists with iron deﬁ-
ciency for children aged 12–24 months (the baseline ages for our
study children) and this falls to just 15.1% by ages 30–42 months
(the follow-up ages of our study children), in a comparable sample
of Colombian children. This proportion is substantially lower than
in most settings where MNP has been successful (see Table 5). We
interpret this as implying that although iron deﬁciency isassociated with childhood anaemia in our population at the start
of our intervention this association is weaker than in other study
settings. Therefore coupled with lower absolute rates of anaemia,
the proportion of study children for whom the iron supple-
mentation element of MNP could plausibly reverse their anaemia
is far lower. This proportion falls rapidly over the ages we inter-
vene to 2.9% by the ages where we collected follow-up. Table 5
shows this is in contrast to studies where MNP has been effective.
For example, in the study of Sooﬁ et al. (2013) in Pakistan, 62.0% of
anaemic children in the control group at follow-up also had iron
deﬁciency resulting in 57.0% having both iron deﬁciency and
anaemia. This contrast makes it unsurprising that we ﬁnd no
effects when others do.
Table 5
Co-existence iron deﬁciency and anaemia in Colombia compared with other MNP studies.
Paper Prevalence of Proportion of anaemia with
iron deﬁciency (%)
Anaemia cut-offb
Country Anaemia IDAa
ENSIN 2010c (12–24 months) Colombia 38.9% 13.2% 34.0 110
ENSIN 2010 (30–42 months) Colombia 19.0% 2.9% 15.1 110
Sooﬁ 2013 (FU) (Sooﬁ et al., 2013) Pakistan 92.0% 57.0% 62.0 120
Jack 2012 (BL) (Jack et al., 2012) Cambodia 74.7% 55.3% 74.1 100
Jack 2012 (FU) (Jack et al., 2012) Cambodia 47.3% 25.0%d 52.9 100
Macharia-Mutie 2012 (FU) (Macharia-Mutie et al., 2012) Kenya 38.4% 21.5% 56.0 110
Macharia-Mutie 2012 (FU) (Macharia-Mutie et al., 2012) Kenya 32.3% 11.8% 36.5 110
Veenemans 2011 (BL) (Veenemans et al., 2011) Tanzania 68.0% 17.0% 25.0 110
Adu-Afawuah 2007 (BL) (Adu-Afarwuah et al., 2007) Ghana 26.3% 17.6% 67.1 100
Adu-Afawuah 2007 (FU) (Adu-Afarwuah et al., 2007) Ghana 32.3% 30.5% 94.4 100
BL¼baseline (weighed average of all intervention groups), FU¼ follow-up (control group only).
a IDA¼ Iron deﬁcient anaemia (deﬁned as having both iron deﬁciency and anaemia).
b Anaemia cut-off is haemoglobin concentration (in g/L) below which child is a deﬁned as anaemic. In all studies the cut-off for deﬁning iron deﬁciency was
12 ng/mL.
c Refers to ENSIN sample described in Section “No dietary substitution”, missing ferritin measures imputed using multiple imputation.
d Figures read off graph.
A. Andrew et al. / SSM -Population Health 2 (2016) 95–104102The high early rates of anaemia that quickly begin to fall after
one year, and the relatively weak association between anaemia
and iron deﬁciency that becomes increasingly weak as children get
older, brings us to children’s diet. Evidence from our household
survey suggests that, in our population even deprived children
consume relatively large quantities of meat and other sources of
highly absorbable haem iron. At follow-up, children ate beef/liver a
mean of 3.77 days out of the past seven days and poultry on 1.86
days (Table 4). This is high relative to children’s diet in Sub-
Saharan Africa-our own (unpublished) data from rural Malawi
showed only 38% of children had eaten any meat in the past three
days. It is likely higher still relative to many areas of South and
Southeast Asia. We also observe a relatively high consumption of
Bienestarina, a government provided blend of ﬂour and milk
powder fortiﬁed with iron and other vitamins and minerals
(although substantially less than our MNP), amongst our study
population. At baseline 65% of children had consumed Bienestar-
ina during the last week. Similarly, our study children were not
eating unusually large quantities of foods with high phytate or
phenolic contents which inhibit iron absorption. Therefore,
descriptives of food intake render it unlikely that anaemia in
Colombian children older than one year, is predominantly caused
by current dietary factors, meaning it is unlikely that MNP sup-
plementation could be useful in this context.
If the anaemia we observe after one year of age is largely
unrelated to current micronutrient intake, why are nearly 70% of
6–12 month olds in Colombia, from the bottom socio-economic
strata, anaemic? This study was not designed to answer this
question and we provide no ﬁrm evidence here. However, we raise
some potential hypotheses and provide correlation evidence
(controlling for age) from under 12 month olds in the ENSIN
sample that is consistent with such hypotheses.
A ﬁrst hypothesis relates to early feeding practices. In our ENSIN
sample we ﬁnd that mean haemoglobin was substantially (5.06 g/L)
higher in infants who were introduced to semi-solid foods between
6 and 8 months (consistent with WHO guidelines) than infants for
whom semi-solids had been introduced prior to 6 months. This is
consistent with an argument that when semi-solids are introduced
before 6 months these are often foods not rich in iron and therefore,
because they reduce the consumption of breast milk, they reduce
overall iron intake (Geissler & Powers, 2010). Similarly, dietary
diversity and meal frequency in the early weaning period appear
correlated with haemoglobin. Infants that met the WHO criteria for
a ‘minimum acceptable diet’ over the past 24 hours had, on average,
a haemoglobin of 1.58 g/L higher than those who did not. Workby Olaya, Lawson, and Fewtrell (2013) also suggests that dietary
diversity and micronutrient intake during the early weaning period
is key to childhood anaemia in Colombia. Their RCT found that a
6 month intervention encouraging parents to continue breastfeed-
ing, offer red meat more than 3 days a week and offer fruit and
vegetables daily increased haemoglobin of 6 month olds. Thus,
while we ﬁnd that diet after 12 months does not contribute greatly
to high rates of early childhood anaemia in Colombia it may be that
the micronutrient content of children’s diet during the early
weaning period is crucial.
The second hypothesis relates to infants’ iron stores at birth,
which form infants’ primary source of iron for the ﬁrst months of
life. Iron status of mothers during pregnancy is a key determinant
of infant iron stores at birth (Allen, 2000). In our ENSIN sample we
ﬁnd that infants (6–12 month olds) whose mothers had taken iron
supplements for 4 or more months of pregnancy had a mean
haemoglobin concentration 3.10 g/L higher than those whose
mothers had not. This is consistent with inadequate iron statuses
of pregnant mothers being a key cause of early childhood anaemia
in Colombia. A related potential factor is early clamping of the
umbilical cord which is an important determinant of low iron
stores in infants (McDonald, Middleton, Dowswell, & Morris,
2013). While we do not have access to reliable information on
timing of cord clamping in Colombia this may be important in
analysing early childhood anaemia in Colombia.Conclusions
Although the population of Colombian infants we studied ﬁtted
the criteria of the WHO guideline for universal MNP supplementa-
tion, they gained no tangible beneﬁt from the intervention in terms
of increased haemoglobin. This suggests that favourable evidence
from other settings on MNP as a population wide intervention for
children 12–24 months is not transferable to a Colombian context.
We suggest that this is likely due to the causes of childhood anae-
mia, and its age proﬁle, being different to those settings. Given the
ineffectiveness and likely inefﬁcacy of MNP administered from 12
months of age, and the pattern of anaemia we see in Colombia and
other countries with a similar proﬁle, future research might usefully
study the effects of earlier interventions (gestation to 12 months)
targeting early feeding practices and infant iron stores.
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